Progress in SARS and MERS vaccines: lessons for the development of COVID-19 vaccine

Q4 Immunology and Microbiology

中华微生物学和免疫学杂志 Pub Date : 2020-05-31 DOI:10.3760/CMA.J.CN112309-20200303-00096

Xingui Tian, R. Zhou

引用次数: 0

Abstract

Safe and effective vaccines are urgently needed to prevent and control the outbreak of COVID-19. SARS-CoV-2 belongs to the genus Betacoronavirus like severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Here we summarized the current progress and problems in the development of vaccines against SARS-CoV and MERS-CoV in order to provide reference for COVID-19 vaccine development. Key words: SARS-CoV-2; COVID-19; SARS; MERS; Vaccine

查看原文本刊更多论文

SARS和MERS疫苗的进展：新冠肺炎疫苗研制的经验教训

预防和控制新冠肺炎疫情急需安全有效的疫苗。严重急性呼吸系统综合征冠状病毒2型与严重急性呼吸综合征冠状病毒（SARS CoV）和中东呼吸综合征病毒（MERS CoV）一样属于Betacoronavirus属。在此，我们总结了目前SARS-CoV和MERS-CoV疫苗研制的进展和存在的问题，为新冠肺炎疫苗研制提供参考。关键词：严重急性呼吸系统综合征冠状病毒2型；新冠肺炎；SARS；MERS；疫苗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中华微生物学和免疫学杂志 Immunology and Microbiology-Virology

CiteScore

0.50

自引率

0.00%

发文量

6906

期刊介绍： Chinese Journal of Microbiology and Immunology established in 1981. It is one of the series of journal sponsored by Chinese Medical Association. The aim of this journal is to spread and exchange the scientific achievements and practical experience in order to promote the development of medical microbiology and immunology. Its main contents comprise academic thesis, brief reports, reviews, summaries, news of meetings, book reviews and trends of home and abroad in this field. The distinguishing feature of the journal is to give the priority to the reports on the research of basic theory, and take account of the reports on clinical and practical skills.